Arrowhead Pharmaceuticals (ARWR) Prepaid Assets (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Prepaid Assets of $21.7 million for Q1 2026, up 35.31% on a QoQ basis from $16.1 million in Q4 2025, and down 8.62% year-over-year from $23.8 million in Q1 2025.
Arrowhead Pharmaceuticals (ARWR) Prepaid Assets (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' Prepaid Assets history runs 17 years deep, the most recent figure standing at $21.7 million for Q1 2026.
- Quarterly Prepaid Assets fell 8.62% year-over-year to $21.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.7 million (down 8.62% YoY) and the FY2025 annual result came in at $13.5 million, up 171.79% from the prior year.
- Prepaid Assets was $21.7 million for Q1 2026 at Arrowhead Pharmaceuticals, up from $16.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $23.8 million in Q1 2025 and bottomed at $4.0 million in Q3 2023.
- A 5-year average of $11.9 million and a median of $10.1 million in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets soared 363.18% — and 2023, when it sank 80.04%.
- Arrowhead Pharmaceuticals' Prepaid Assets stood at $8.4 million in 2022, then retreated by 15.55% to $7.1 million in 2023, then soared by 31.84% to $9.4 million in 2024, then soared by 71.4% to $16.1 million in 2025, then surged by 35.31% to $21.7 million in 2026.
- Business Quant data shows ARWR's Prepaid Assets at $21.7 million in Q1 2026, $16.1 million in Q4 2025, and $13.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.72 Mn |
| Dec 31, 2025 | 16.05 Mn |
| Sep 30, 2025 | 13.52 Mn |
| Jun 30, 2025 | 13.16 Mn |
| Mar 31, 2025 | 23.77 Mn |
| Dec 31, 2024 | 9.37 Mn |
| Sep 30, 2024 | 4.97 Mn |
| Jun 30, 2024 | 9.21 Mn |
| Mar 31, 2024 | 11.02 Mn |
| Dec 31, 2023 | 7.10 Mn |
| Sep 30, 2023 | 4.03 Mn |
| Jun 30, 2023 | 10.05 Mn |
| Mar 31, 2023 | 14.44 Mn |
| Dec 31, 2022 | 8.41 Mn |
| Sep 30, 2022 | 20.20 Mn |
| Jun 30, 2022 | 6.76 Mn |
| Mar 31, 2022 | 7.80 Mn |
| Dec 31, 2021 | 2.80 Mn |
| Sep 30, 2021 | 4.36 Mn |
| Jun 30, 2021 | 1.70 Mn |